Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akoya Biosciences, Inc.

1.26
-0.0400-3.08%
Post-market: 1.260.00000.00%17:31 EDT
Volume:106.89K
Turnover:136.50K
Market Cap:62.84M
PE:-1.31
High:1.31
Open:1.31
Low:1.25
Close:1.30
Loading ...
Jun 04, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 02, 2025

Major Issues Report

Form 8-K - Current report
May 21, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 13, 2025

Major Issues Report

Form 8-K - Current report
May 12, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 29, 2025

Major Issues Report

Form 8-K - Current report
Apr 29, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 29, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 28, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 04, 2025

Major Issues Report

Form 8-K - Current report
Apr 04, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 04, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Mar 18, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Mar 17, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Mar 17, 2025

Major Issues Report

Form 8-K - Current report
Mar 17, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 17, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 04, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations